Here’s RxMM’s press release on their entry into California in conjunction with Boston Securities Group Pty Ltd
We presume the expertise they build in California will set them up for entry into the Australian market when a legislative framework exists.
30th November 2015 AUSTRALIAN COMPANY JOINS CALIFORNIA’s MEDICAL MARIJUANA RUSH
RxMM Health to Apply Leading Edge Hydroponic Technology to Pursue Lucrative Business Opportunities in Medical Marijuana – America’s Fastest Growing Industry. PERTH, WA, AUSTRALIA / ACCESSWIRE /
November 30th , 2015 / Boston Securities Group Pty Ltd., today announced the incorporation of RxMM Health Pty Ltd. RxMM Health is establishing operations in Southern California and will install state-ofthe-art hydroponic production technology in climate controlled greenhouses for the cultivation of selected marijuana plant strains during the first half of 2016.
Climate controlled greenhouse cultivation eliminates seasonal variability and hydroponic cultivation maximizes quality control and production yield. To oversee production, RxMM Health has recruited one of the world’s foremost hydroponic cultivation experts with over 30 years of international experience and has engaged leading US legal consultants to provide guidance on market and regulatory requirements.
The Company will work in close liaison with relevant authorities as well as scientific and market experts to produce the most cost effective plant materials, for the legal production and sale of medical cannabis to authorised distributors and dispensaries throughout California.
The Company has a binding LOI for the off-take and sale of its annual cannabis crop, which, within 2 years, is expected to exceed US$20 million. RxMM Health has also reached in principle agreements with two highly acclaimed US medical specialists to oversee its R&D programmes for the development of therapeutic prescription medicines based on cannabis extracts.
RxMM Health is founded on the substantial body of evidence resulting from clinical trials and increased legislation by twenty three US State Governments, that cannabinoids have a beneficial impact on numerous debilitating illnesses. These include but are not limited to chronic pain relief for terminal cancer sufferers, reducing the spread of cancer, reducing the occurrence and severity of epileptic seizures and certain other neurological disorders, and do so in an environmentally sustainable manner. RxMM Health intends to direct a percentage of its profits to medical support groups and is currently raising capital from sophisticated investors.
The Company plans to have its shares publicly traded on the Australian Stock Exchange (ASX) by Q3-2016.
RxMM Health Pty Ltd. was established by Boston Securities Group in Nov. 2015 on behalf of an international US/Australian consortium for the initial purpose of supplying the Californian market with pharmaceutical-grade medical cannabis under California Proposition 215, also known as the Medical Marijuana Use Initiative or the Compassionate Use Act. The Company has initiated the process for issue of permits from the San Diego County, for growing and distributing medical marijuana.
About Medical Marijuana in Australia The Australian Federal Government announced it will legalise the growing of cannabis for medicinal purposes and the Victorian State Government announced it will legalise locally grown medical cannabis. Two other eastern states have committed to clinical trials. RxMM Health plans to conduct research and clinical trials in Australia with the intention of supplying the Australian medical marijuana market when government licences permit growing and dispensing. About Boston Securities Group Boston Securities Group is a privately owned firm specialising in company formation, corporate advisory, business development and capital markets (equity).
Here’s a story in BusinessNews Australia